Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 35 entries
View as:

Safety, Tolerability, and Pharmacokinetic Parameters of Grammidin With Anesthetic, a Metered Spray in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06857890 Org: User:
Start: 12/09/24 End: 12/01/26 Due: 12/01/27

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

Phase: N/A Priority: Normal
NCT ID: NCT06379542 Org: User:
Start: 12/04/23 End: 12/31/25 Due: 12/31/26

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Phase: N/A Priority: Normal
NCT ID: NCT05273619 Org: User:
Start: 05/23/22 End: 07/29/22 Due: 07/29/23

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Phase: N/A Priority: Normal
NCT ID: NCT03189537 Org: User:
Start: 10/03/10 End: 10/10/11 Due: 10/10/12

Food Effect on the Bioavailability of 4-MUST, Tablets, 128 mg

Phase: N/A Priority: Normal
NCT ID: NCT06342804 Org: User:
Start: 03/19/24 End: 12/31/24 Due: 12/31/25

Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05558462 Org: User:
Start: 08/22/22 End: 12/07/22 Due: 12/07/23

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.

Phase: N/A Priority: Normal
NCT ID: NCT03206346 Org: User:
Start: 01/31/12 End: 08/31/13 Due: 08/31/14

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Phase: N/A Priority: Normal
NCT ID: NCT05269290 Org: User:
Start: 09/23/21 End: 07/15/22 Due: 07/15/23

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

Phase: N/A Priority: Normal
NCT ID: NCT03191097 Org: User:
Start: 08/31/14 End: 03/31/15 Due: 03/31/16

A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Phase: N/A Priority: Normal
NCT ID: NCT05544916 Org: User:
Start: 08/05/22 End: 05/04/23 Due: 05/04/24

Safety and Pharmacokinetics of Dioxidin, Solution for Topical and External Use, 0.25 mg/ml and Dioxidin, Solution for Infusion and External Use, 5 mg/ml in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05505097 Org: User:
Start: 05/04/22 End: 12/19/22 Due: 12/19/23

A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders

Phase: N/A Priority: Normal
NCT ID: NCT05586789 Org: User:
Start: 10/12/22 End: 01/03/23 Due: 01/03/24

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06552624 Org: User:
Start: 07/07/21 End: 08/31/22 Due: 08/31/23

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06098742 Org: User:
Start: 04/25/24 End: 09/20/25 Due: 09/20/26

Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06096571 Org: User:
Start: 06/15/24 End: 12/30/24 Due: 12/30/25

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

Phase: N/A Priority: Normal
NCT ID: NCT06315400 Org: User:
Start: 12/19/23 End: 12/31/25 Due: 12/31/26

Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo

Phase: N/A Priority: Normal
NCT ID: NCT06321341 Org: User:
Start: 01/24/24 End: 12/31/26 Due: 12/31/27

Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05216497 Org: User:
Start: 10/06/21 End: 04/25/22 Due: 04/25/23

Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo

Phase: N/A Priority: Normal
NCT ID: NCT05430217 Org: User:
Start: 01/28/22 End: 05/09/22 Due: 05/09/23

Study of the Effect of Food Intake on the Bioavailability of XC8 10 mg Film-coated Tablets

Phase: N/A Priority: Normal
NCT ID: NCT05294250 Org: User:
Start: 02/01/22 End: 02/26/22 Due: 02/26/23

Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin

Phase: N/A Priority: Normal
NCT ID: NCT06342778 Org: User:
Start: 02/27/24 End: 05/02/24 Due: 05/02/25

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Phase: N/A Priority: Normal
NCT ID: NCT05269329 Org: User:
Start: 04/26/21 End: 10/26/21 Due: 10/26/22

Pharmacokinetics and Bioequivalence of Molnupiravir, 200 mg Capsules and Lagevrio, 200 mg Capsules in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05412173 Org: User:
Start: 04/22/22 End: 06/02/22 Due: 06/02/23

Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia

Phase: N/A Priority: Normal
NCT ID: NCT06842966 Org: User:
Start: 10/17/24 End: 12/31/26 Due: 12/31/27

Study to Evaluate the Efficacy and Safety of Using Different Doses of Graminidin With Anesthetic for the Treatment of Acute Infectious-inflammatory Diseases of the Pharynx in Comparison With Septolete Total, Lozenges

Phase: N/A Priority: Normal
NCT ID: NCT06843018 Org: User:
Start: 11/14/24 End: 12/31/26 Due: 12/31/27